NCT06972927

Brief Summary

The investigators present a diet intervention study, to be conducted as a within-subject design, to assess the effect of the provision of iron biofortified microgreens on iron intake and status in women of reproductive age and postmenopausal women. This will be investigated by providing smoothie kits for 28 days containing these microgreens and determining the impact on iron biomarkers. The investigators will also assess habitual diet, BMI, physical activity and gastrointestinal symptoms. This study will be a proof-of-concept exploratory study to explore diet based biofortification through vertical farming systems.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 6, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 15, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2026

Completed
Last Updated

April 30, 2026

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

May 6, 2025

Last Update Submit

April 29, 2026

Conditions

Keywords

vertical farmingiron biomarkersiron statusbiofortificationmicrogreens

Outcome Measures

Primary Outcomes (5)

  • Haemoglobin status change from baseline

    Iron status changes in haemoglobin

    Measured at study day 1 and on study day 28

  • Serum iron status change from baseline

    Iron status changes in serum iron

    Measured at study day 1 and on study day 28

  • Ferritin status change from baseline

    Iron status changes in ferritin

    Measured at study day 1 and on study day 28

  • CRP change from baseline

    Changes in CRP

    Measured at study day 1 and on study day 28

  • Dietary iron intake changes compared to habitual diet

    Dietary iron intake changes in iron intake compared to habitual diet measured though food diaries

    every study day (28 days)

Secondary Outcomes (2)

  • Serum Vitamin B12 status change from baseline

    Measured on study day 1 and on study day 28

  • Adherence to consumption of microgreens/smoothie

    every study day (28 days)

Study Arms (1)

Vertigreens

EXPERIMENTAL

Phase 1: Habitual diet (1 week) Phase 2: Vertigreens diet: One smoothie a day containing biofortified microgreens (4 weeks)

Other: Smoothie containing iron biofortified microgreens

Interventions

30g of iron biofortified microgreens consumed within a smoothie for 28 days

Vertigreens

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy females
  • of reproductive age (18-49)
  • postmenopausal (not had their period for an entire year)

You may not qualify if:

  • Supplementing iron or vitamin B12
  • Smoking or vaping
  • Taking anticoagulant medication (blood thinners) except for Aspirin 75mg
  • Anyone who is planning to be pregnant, is pregnant or breastfeeding
  • Anyone with iron or vitamin B12 deficiency anaemia
  • Anyone with history of anaemia in the past 3 months that required treatment
  • Anyone who has Hb \<120 g/L (12 g/dL) at screening
  • Anyone with food allergies to banana, mango, pineapple, coconut
  • Anyone with coeliac disease
  • Anyone suffering from a psychiatric disorder or any type of substance abuse
  • Anyone with Type 1 diabetes and Type 2 diabetes
  • Anyone suffering from unregulated thyroid disease
  • Anyone with gastrointestinal conditions or bariatric surgery
  • Anyone with haematological conditions including Thrombocytopaenia and Sickle cell anaemia
  • Anyone with unsuitable veins for blood sampling
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rowett Institute, University of Aberdeen

Aberdeen, AB25 2ZD, United Kingdom

RECRUITING

Study Officials

  • Alexandra Johnstone, Prof

    University of Aberdeen, Rowett Institute of Nutrition and Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alexandra Johnstone, Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2025

First Posted

May 15, 2025

Study Start

May 1, 2025

Primary Completion

May 4, 2026

Study Completion

May 4, 2026

Last Updated

April 30, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations